Stay updated with breaking news from Stephen Uden. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biotech Stocks in Play - Rallybio Corporation (Nasdaq: RLYB) Soars on Collaboration News and Equity Investment of $6.6 million from Johnson & Johnson Innovation
-- Received Protocol Assistance Feedback from European Medicines Agency on the Phase 2 Study for RLYB212; Company to Proceed Forward with Clinical Trial Application Process in Europe -- -- Phase 2...
-- 100 mg Results Demonstrated a Mean Reduction of Greater than 93% in Free C5 with Low Volume Once-a-Week Subcutaneous Dosing -- -- Data Supports the Study of RLYB116 as a Differentiated...
-- 100 mg Results Demonstrated a Mean Reduction of Greater than 93% in Free C5 with Low Volume Once-a-Week Subcutaneous Dosing ---- Data Supports the Study of RLYB116 as a Differentiated Therapeutic for the Treatment of Generalized Myasthenia Gravis ---- Company Announces Extension of Runway to 3Q 2025 As Part of Po...
/PRNewswire/ -- WHAT: Join the National Organization for Rare Disorders (NORD) Oct. 15-17, 2023 in Washington for the Rare Diseases and Orphan Products...